home / stock / ipix / ipix news

IPIX News and Press, Innovation Pharmaceuticals Inc From 11/15/22

Stock Information
Company Name: Innovation Pharmaceuticals Inc
Stock Symbol: IPIX
Market: OTC
Website: ipharminc.com
Menu
IPIX IPIX Quote IPIX Short IPIX News IPIX Articles IPIX Message Board
Get IPIX Alerts

News, Short Squeeze, Breakout and More Instantly...
IPIX - Scientific Poster on Innovation Pharmaceuticals Brilacidin to be Presented at 2022 Chemical and Biological Defense Science & Technology Conference

·         BARDA prioritizing the development of host-targeting and pathogen-agnostic therapeutics for treatment of hospitalized COVID-19 and other serious diseases of the lung Wakefield, MA - ( NewMediaWire ) - November 15, 2022 - Innovation P...
IPIX - NHS Medical Director for Specialised Services Calls New Laser Technology for Epilepsy "Game-Changing Breakthrough"

Innovation Pharmaceuticals believes U.K. launch of MRgLITT for refractory focal epilepsy substantiates its investment in advanced laser technology of BT BeaMedical WAKEFIELD, MA, Oct. 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Innovation Pharmaceuticals (OTCQB: I...

IPIX - Innovation Pharmaceuticals Announces Publication of Scientific Article on the Antifungal Activity of Brilacidin

In pre-clinical studies, Brilacidin shown to synergize with marketed antifungals against pathogenic species of aspergillosis , candidiasis , cryptococcosis and mucormycosis , and further exhibited potent stand-alone efficacy against Cryptococcus neoformans These da...

IPIX - New In Vitro Data Supporting the Broad-Spectrum Antiviral Activity of Innovation Pharmaceuticals' Brilacidin Presented at 2022 Military Health System Research Symposium

Brilacidin shown to inhibit multiple alphaviruses, the bunyavirus Rift Valley Rift Fever, and Echovirus (a non-enveloped picornavirus) WAKEFIELD, MA / ACCESSWIRE / September 15, 2022 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, t...
IPIX - Innovation Pharmaceuticals' Investment in BT BeaMedical Helping Advance New Surgical Laser Platform

WAKEFIELD, MA / ACCESSWIRE / September 13, 2022 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today updated shareholders on recent progress by BT BeaMedical Technologies Ltd. ("BeaMed") (formerly known as Squalus Medical Ltd.) to advan...

IPIX - Innovation Pharmaceuticals Announces NIH/NIAID-Affiliated Researchers to Evaluate Brilacidin's Treatment Potential Against Monkeypox

WAKEFIELD, MA / ACCESSWIRE / August 5, 2022 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today announced that Brilacidin, the Company's defensin-mimetic drug candidate exhibiting broad-spectrum antiviral properties, is to be evaluated...

IPIX - Provider and Payer Analysis Supports Potential Commercialization of Innovation Pharmaceutical's Brilacidin as a Novel Oral Mucositis Drug Candidate

WAKEFIELD, MA / ACCESSWIRE / July 22, 2022 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today provided an update on the Company's Brilacidin program in Oral Mucositis (OM). Brilacidin, delivered as an oral rinse, was shown in Phase 2 ...
IPIX - Innovation Pharmaceuticals Announces New Antiviral Research on Brilacidin in Bunyaviruses and Alphaviruses to be Presented at the 2022 Military Health System Research Symposium

Research was performed by scientists at George Mason University's Center for Infectious Disease Research (formerly NCBID) WAKEFIELD, MA / ACCESSWIRE / June 28, 2022 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today announced n...

IPIX - Innovation Pharmaceuticals Reports Brilacidin Inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 Variants Based on In Vitro Testing by NIH/NIAID-Sponsored and Rutgers University Researchers

WAKEFIELD, MA / ACCESSWIRE / June 23, 2022 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today reported that Brilacidin, the Company's defensin-mimetic drug candidate exhibiting broad-spectrum antiviral activity, inhibited the Omicro...

IPIX - Innovation Pharma acquires minority stake in Israeli med-tech company Squalus

Innovation Pharmaceuticals (OTCQB:IPIX) said it acquired a minority stake in Israeli medical device maker Squalus Medical. IPIX said Squalus is developing a novel laser-based thermal ablation technology called StingRay Laser System to treat previously inoperable cases of epilepsy an...
Previous 10 Next 10